TDAM USA’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,506
Closed -$670K 248
2019
Q4
$670K Sell
3,506
-2,951
-46% -$532K 0.04% 191
2019
Q3
$1.09M Sell
6,457
-5,086
-44% -$829K 0.08% 164
2019
Q2
$1.93M Sell
11,543
-520
-4% -$72K 0.14% 129
2019
Q1
$1.77M Sell
12,063
-36,662
-75% -$5.32M 0.13% 130
2018
Q4
$6.51M Sell
48,725
-8,066
-14% -$1.32M 0.47% 65
2018
Q3
$10.5M Buy
56,791
+1,578
+3% +$290K 0.64% 47
2018
Q2
$9.21M Sell
55,213
-3,783
-6% -$607K 0.58% 54
2018
Q1
$9.93M Buy
58,996
+3,450
+6% +$579K 0.6% 53
2017
Q4
$9.09M Buy
55,546
+7,790
+16% +$1.4M 0.52% 61
2017
Q3
$9.79M Sell
47,756
-2,883
-6% -$670K 0.58% 60
2017
Q2
$12.4M Buy
50,639
+151
+0.3% +$35.5K 0.64% 53
2017
Q1
$12.1M Sell
50,488
-76
-0.2% -$17.7K 0.61% 60
2016
Q4
$10.6M Sell
50,564
-882
-2% -$183K 0.56% 64
2016
Q3
$11.8M Sell
51,446
-1,036
-2% -$253K 0.59% 59
2016
Q2
$12.1M Sell
52,482
-13
-0% -$3K 0.6% 58
2016
Q1
$14.1M Buy
52,495
+14,493
+38% +$4.15M 0.69% 50
2015
Q4
$11.9M Buy
38,002
+12,093
+47% +$3.6M 0.58% 59
2015
Q3
$7.04M Buy
25,909
+7,422
+40% +$2.28M 0.36% 89
2015
Q2
$5.61M Buy
+18,487
New +$5.51M 0.25% 108

Other funds holding AGN

TDAM USA's AGN Position: Q1 2020 in Review

TDAM USA sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 3,506 shares — an estimated $670K sold.

TDAM USA first reported a position in AGN in Q2 2015 and held it in 19 quarters. The position peaked at $14.1M in Q1 2016. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • TDAM USA reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • TDAM USA sold 3,506 Allergan plc shares in Q1 2020, an estimated $670K.
  • TDAM USA first reported a position in Allergan plc in Q2 2015 and held it in 19 quarters.
  • TDAM USA's Allergan plc position peaked at $14.1M in Q1 2016.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on TDAM USA's 13F filing for Q1 2020, filed 15 May 2020.